201 related articles for article (PubMed ID: 16575260)
1. The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant.
Cetin H; Yalaz M; Akisu M; Karapinar DY; Kavakli K; Kultursay N
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):213-6. PubMed ID: 16575260
[TBL] [Abstract][Full Text] [Related]
2. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
3. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
Brady KM; Easley RB; Tobias JD
Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
[TBL] [Abstract][Full Text] [Related]
4. Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants.
Olomu N; Kulkarni R; Manco-Johnson M
J Perinatol; 2002 Dec; 22(8):672-4. PubMed ID: 12478454
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute pulmonary haemorrhage in extremely preterm infants with recombinant activated factor VII.
Poralla C; Hertfelder HJ; Oldenburg J; Müller A; Bartmann P; Heep A
Acta Paediatr; 2010 Feb; 99(2):298-300. PubMed ID: 19839953
[No Abstract] [Full Text] [Related]
6. Treatment of acute bleeds with recombinant activated factor VII during immune tolerance therapy.
Petrini P; Klementz G
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S143-6. PubMed ID: 9819046
[TBL] [Abstract][Full Text] [Related]
7. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
Fischer D; Schloesser R; Buxmann H; Veldman A
J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
[TBL] [Abstract][Full Text] [Related]
8. Recombinant activated factor VII for treatment of intramuscular haemorrhages: a comparison of early versus late treatment.
Lusher JM
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S111-4. PubMed ID: 9819040
[TBL] [Abstract][Full Text] [Related]
9. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
Bishop CV; Renwick WE; Hogan C; Haeusler M; Tuckfield A; Tatoulis J
Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
[TBL] [Abstract][Full Text] [Related]
10. Life-threatening hemorrhage in neonates: management with recombinant activated factor VII.
Veldman A; Fischer D; Voigt B; Beyer PA; Schlösser R; Allendorf A; Kreuz W
Intensive Care Med; 2002 Nov; 28(11):1635-7. PubMed ID: 12415453
[TBL] [Abstract][Full Text] [Related]
11. Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa.
Hicks K; Peng D; Gajewski JL
Bone Marrow Transplant; 2002 Dec; 30(12):975-8. PubMed ID: 12476294
[TBL] [Abstract][Full Text] [Related]
12. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa).
Segal S; Shemesh IY; Blumenthal R; Yoffe B; Laufer N; Ezra Y; Levy I; Mazor M; Martinowitz U
Arch Gynecol Obstet; 2003 Oct; 268(4):266-7. PubMed ID: 14504866
[TBL] [Abstract][Full Text] [Related]
13. Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage.
Heslet L; Nielsen JD; Levi M; Sengeløv H; Johansson PI
Crit Care; 2006; 10(6):R177. PubMed ID: 17184515
[TBL] [Abstract][Full Text] [Related]
14. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
[TBL] [Abstract][Full Text] [Related]
15. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency.
Huang WY; Kruskall MS; Bauer KA; Uhl L; Shaz BH
Transfusion; 2004 Nov; 44(11):1562-6. PubMed ID: 15504160
[TBL] [Abstract][Full Text] [Related]
16. Management of coagulopathy with recombinant factor VIIa in a neonate with echovirus type 7.
Tancabelic J; Haun SE
Pediatr Blood Cancer; 2004 Aug; 43(2):170-6. PubMed ID: 15236286
[TBL] [Abstract][Full Text] [Related]
17. Recombinant Activated Factor VIIa (rFVIIa) Treatment in Very-Low-Birth-Weight (VLBW) Premature Infants with Acute Pulmonary Hemorrhage: A Single-Center, Retrospective Study.
Cosar H; Isik H; Cakır SC; Yar N; Goksen B; Tokbay H; Kertmen H; Erdoğan N; Durak I
Paediatr Drugs; 2017 Feb; 19(1):53-58. PubMed ID: 27826851
[TBL] [Abstract][Full Text] [Related]
18. Recombinant activated factor VII in hemophagocytic lymphohistiocytosis with disseminated intravascular coagulation.
Zhuang JL; Jiang QW; Xu Y; Wang SJ
Chin Med J (Engl); 2011 Oct; 124(19):3189-91. PubMed ID: 22040579
[TBL] [Abstract][Full Text] [Related]
19. Recombinant activated factor seven in acute life-threatening bleeding in neonates: report on three cases and review of literature.
Hünseler C; Kribs A; Eifinger F; Roth B
J Perinatol; 2006 Nov; 26(11):706-13. PubMed ID: 17066067
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of recombinant activated Factor VII in patients with massive uncontrolled bleeding: a retrospective observational analysis.
Berkhof FF; Eikenboom JC
Transfusion; 2009 Mar; 49(3):570-7. PubMed ID: 19040498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]